← All peptides
Cognitive & Nootropic
Research Chemical

Adamax

Also known as: Adamax

Adamax is a proprietary nootropic peptide product marketed for cognitive enhancement and neuroprotection. It is sold as a research chemical with limited public pharmacological data.

Last updated

Mechanism of Action

Adamax is marketed as an analogue within the ACTH/Semax-derived neuropeptide family that is believed to act on central melanocortin and neurotrophic signaling. Proposed mechanisms include upregulation of BDNF and nerve growth factor (NGF), modulation of dopaminergic and serotonergic transmission, and antioxidant or anti-inflammatory protection of cortical neurons. As with related short peptides, these effects are extrapolated from the broader class because peer-reviewed, compound-specific studies are scarce.

Half-life
Not established; expected short for an unprotected neuropeptide (minutes to a few hours)
Administration Routes
intranasal, subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Marketed for memory and learning support
  • Proposed neurotrophic (BDNF/NGF) stimulation
  • Reported neuroprotective and antioxidant effects
  • Positioned for focus and mental stamina
  • Framed as supporting stress resilience

Potential Side Effects

  • Limited human safety data
  • Possible overstimulation or restlessness
  • Headache or irritability reported anecdotally
  • Nasal irritation with intranasal use

Common Dosing

For research use only and not medical advice: community references for ACTH/Semax-class peptides typically cite low microgram-to-low-milligram amounts given intranasally or subcutaneously once or twice daily. No validated dosing exists for Adamax specifically.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy or breastfeeding
  • Known peptide hypersensitivity
  • Psychiatric instability sensitive to stimulation

No notable studies catalogued for Adamax yet.

It is sold as a nootropic peptide for memory, focus, and neuroprotection research, with proposed neurotrophic effects.

No. Compound-specific clinical data are lacking, and claims are extrapolated from related ACTH/Semax-type peptides.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.